Practice
Featured experience
Incora emerges from chapter 11
We advised an ad hoc group of secured noteholders in connection with Incora’s chapter 11 proceedings
Venture Global $1.75 billion IPO
We advised Venture Global on its IPO and NYSE listing
Interactive Brokers claims for domestic production activities deductions
We are representing Interactive Brokers
Advice to multiple companies on potential tax refunds under the Varian ruling
We are representing clients in refund claims
Merck $6 billion notes offering
The investment-grade notes offering consists of six tranches
Weyerhaeuser $750 million notes offering
The investment-grade notes are due 2026
Bloom Energy $632.5 million green convertible notes and capped call transactions
The 3% green convertible senior notes are due 2028
Mirion Technologies $52.9 million secondary offering
The shares are listed on the NYSE
TPG acquisition of Angelo Gordon
We are advising TPG on tax and financing matters
Corteva $1.2 billion senior notes offering
The investment-grade notes are due 2026 and 2033
Schlumberger $1 billion senior notes offering
The investment-grade notes are due 2028 and 2033
Black Spade Acquisition $23 billion combination with VinFast
We are advising Black Spade on its de-SPAC transaction
GSK exclusive licensing agreement with Scynexis
We advised GSK on the transaction
Olema Pharmaceuticals $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market